BCRX icon

BioCryst Pharmaceuticals

133 hedge funds and large institutions have $826M invested in BioCryst Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 25 reducing their positions, and 11 closing their positions.

Holders
133
Holders Change
+10
Holders Change %
+8.13%
% of All Funds
2.88%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
21
Increased
52
Reduced
25
Closed
11
Calls
$8.87M
Puts
$5.79M
Net Calls
+$3.07M
Net Calls Change
+$2.42M
Name Market Value Shares Shares
Change
Shares
Change %
LTFS
126
Ladenburg Thalmann Financial Services
Florida
$4K 489 +100 +26%
IFAM
127
Institutional & Family Asset Management
Colorado
$3K 400
US Bancorp
128
US Bancorp
Minnesota
$3K 346 +346 New
TRCT
129
Tower Research Capital (TRC)
New York
$3K 353 +353 New
FHA
130
Flagship Harbor Advisors
Massachusetts
$2K 300
EAM
131
Eventide Asset Management
Massachusetts
-1,047,000 Closed
Ameriprise
132
Ameriprise
Minnesota
-118,223 Closed
RA
133
Royce & Associates
New York
-84,855 Closed
WCM
134
Weld Capital Management
New York
-32,423 Closed
RJFSA
135
Raymond James Financial Services Advisors
Florida
-28,703 Closed
Wolverine Trading
136
Wolverine Trading
Illinois
-27,701 Closed
QIM
137
Quantitative Investment Management
Virginia
-23,800 Closed
SSA
138
Schonfeld Strategic Advisors
New York
-11,000 Closed
Simplex Trading
139
Simplex Trading
Illinois
-3,682 Closed
MAM
140
Meeder Asset Management
Ohio
-786 Closed
SWM
141
SeaCrest Wealth Management
New York
-500 Closed
OC
142
Oakworth Capital
Alabama
$0 100
FANJ
143
Financial Architects (New Jersey)
New Jersey
$0 30
AG
144
Advisor Group
Arizona
$0 50
CFGS
145
Concourse Financial Group Securities
Alabama
WVP
146
Worth Venture Partners
New Jersey
DAM
147
DLD Asset Management
New York
Susquehanna International Group
148
Susquehanna International Group
Pennsylvania